DCGI approves MSD India’s Keytruda for treating cervical and esophageal cancers
Keytruda is now approved for 10 indications in six different types of cancers in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Keytruda
Amgen says Lumakras plus immunotherapy for lung cancer needs further study
The findings are the first indication of how well Lumakras works in combination with drugs that help the immune system attack…
Pfizer and BioNTech’s COVID-19 vaccine Comirnaty tops the list of best-selling drugs
Ends the nine-year reign of AbbVie’s Humira as the world’s best-selling pharma product
Nektar stops clinical trials for key cancer drug
The trials that Nektar stopped included those involving a combination of its drug Bempegaldesleukin with Bristol Myers Squibb Co’s…
Merck to stop Keylynk-010 trial evaluating Keytruda in combination with Lynparza
In an interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in the overall survival, one of the…
Early research suggests Merck cancer drug may target dormant HIV
Antiretroviral treatments now allow many HIV patients to lead normal lives, but the drugs do not completely remove the virus from…
Key unmet needs in HNSCC may be partly addressed by clinical development in next decade: GlobalData
The next decade may see the introduction of personalised therapy options in locally advanced HNSCC settings along with…
US FDA approves KEYTRUDA from Merck for adults with relapsed or refractory cHL
KEYTRUDA is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after frontline therapy
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Merck’s Keytruda shows mixed results in phase 3 trial for small cell lung cancer
While the blockbuster drug showed improvement in overall survival for patients treated with Keytruda in combination with…